Andrew J. Wagner, Md, Phd

This study tested nilotinib, a drug used for leukemia, in 17 people with a rare joint tumor called PVNS (or giant cell tumor) that had come back or spread. The goal was to see if the drug could stop the tumor from growing or improve symptoms. Results focused on how long the tumor…